Search Results

208 results

  1. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 13

    Development of codominant markers related to powdery mildew resistance from N. tomentosiformis origin

    JULIO E.(1); MALPICA A.(2); COTUCHEAU J.(1); BACHET S.(2); VOLPATTI R.(1); DECORPS C.(1); DORLHAC DE BORNE F.(1)
    (1) SEITA - Imperial Brands, Leaf Research, Bergerac, France; (2) Bergerac Seeds and Breeding, Bergerac, France
    Powdery mildew is a common tobacco plant fungal disease which can reduce growers' crop yields, particularly in South Africa, Asia and Europe. Three different resistance sources are known, coming from wild tobacco species N. tomentosiformis and N. ...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 45

    Meta-analysis of two biomarkers of exposure of tobacco products

    AYALA-FIERRO F.(1); ELAMIN A.(2); FROST-PINEDA K.(3); JIN T.(3); PRASAD G.L.(3); SARKAR M.(4); SCHMIDT E.(3); VERRON T.(5)
    (1) ITG Brands LLC, Greensboro, NC, U.S.A.; (2) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (3) RAI Services Company, Winston-Salem, NC, U.S.A.; (4) Altria Client Services LLC, Richmond, VA, U.S.A.; (5) SEITA - Imperial Brands, Paris, France
    In the context of tobacco products, broadly two types of biomarkers exist, biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH). BoE measure exposure to tobacco constituents, e.g. carbon monoxide (CO) and nicotine equivalents (NEQs). The ...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 56

    Perceptions of the relative harm of electronic cigarettes compared with smoking in the U.S.A.: analysis of the Population Assessment of Tobacco and Health (PATH) study data, 2013-2016

    O’CONNELL G.(1); WALELE T.(1); CAHOURS X.(2); THOMPSON J.(1); VERRON T.(2)
    (1) Imperial Tobacco Limited, Bristol, U.K.; (2) SEITA - Imperial Brands, Paris, France
    Electronic cigarettes (e-cigarettes) have been characterised as significantly less harmful than smoked tobacco by an increasing number of public health authorities. Despite this, U.S. adults remain poorly informed about the relative risk of these products ...
  4. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 58

    A consortium approach for consumer-reported outcome measures to assess tobacco- and nicotine-containing products

    ACQUADRO C.(1) on behalf of the CORESTA CROM Task Force: AYALA-FIERRO F.(2); BLACK R.(3); CAHOURS X.(4); CHREA C.(5); CURTIN G.(6); GILES L.(7); McCAFFREY S.(3); PARK C.H.(8); PRASAD K.(9); SHERWOOD N.(10); SHIFFMAN S.(11); SMITH J.(6); SPIES E.(5)
    (1) Mapi Research Trust, Lyon, France; (2) ITG Brands, Greensboro, NC, U.S.A.; (3) Altria Client Services, Richmond, VA, U.S.A.; (4) SEITA - Imperial Brands, Paris, France; (5) Philip Morris Products S.A., Neûchatel, Switzerland; (6) RAIS, Winston-Salem, NC, U.S.A.; (7) JT Int'l SA, Genève, Switzerland; (8) KT&G Research Institute, Daejeon, Republic of Korea; (9) British American Tobacco, Southampton, U.K.; (10) Neil Sherwood Consulting, Commugny, Switzerland; (11) Pinney Associates, Pittsburgh, PA, U.S.A.
    In the tobacco space, consumer-reported outcome measures (CROM) are essential for understanding motivations, subjective effects, and behavior. Such measures have become particularly important with the advent of candidate modified risk tobacco products ...
  5. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 65; CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, APPOST 15

    Analysis of mainstream cigarette smoke constituents prioritized by the World Health Organization in a core collection of tobacco accessions: variability and correlations

    CAHOURS X.(2); JULIO E.(1); VERRON T.(2); DORLHAC DE BORNE F.(1)
    (1) SEITA - Imperial Brands, Leaf Research, Bergerac, France; (2) SEITA - Imperial Brands, Scientific Research, Paris, France
    Among the different strategies proposed for tobacco regulation, the WHO study group on Tobacco Product Regulation (TobReg) has proposed mandating ceilings on smoke constituents. These constituents were selected according to their potential toxicity, their ...
  6. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 057

    CTP submissions – tips and insight for preparing an electronic submission

    SMITH J.K.(1); SHOLTES D.(1); GLATSTEIN S.(1); ANGERMEIER G.(2)
    (1) US Food and Drug Administration (FDA), Silver Spring, MD, USA; (2) WiseDesign, McLean, VA, USA
    Currently, tobacco product submissions are organized differently across application types and often, across applicants, and are received in a format that is not amenable for reviewers to organize and easily find what they need. This “unstructured” format ...
  7. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 079

    Comparison of the acetaldehyde, formaldehyde, and acrolein yields in cigars under different smoking regimens using a linear cigarette smoking machine

    YOUNG M.; CECIL T.L.; JOHNSON T.; FENG S.
    US Food and Drug Administration (FDA), Calverton, MD, USA
    Currently, there is very little information on the mainstream smoke yields of carbonyl compounds (e.g., formaldehyde, acetaldehyde, and acrolein) in cigar tobacco products. This study used a standard linear smoking machine and puffing protocols to provide ...
  8. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 091

    Tobacco-specific nitrosamines in the mainstream smoke of commercial little cigars

    EDWARDS S.H.(1); HASSINK M.(1); TAYLOR K.M.(1); WATSON C.(2); KUKLENYIK P.(2); WANG R.(2); CHEN P.(2); VALENTIN-BLASINI L.(2); KIMBRELL B.(2)
    (1) US Food and Drug Administration (FDA), Silver Spring, MD, USA; (2) Centers for Disease Control and Prevention, Atlanta, GA, USA
    Cigars are among the broad variety of deemed tobacco products that have been less extensively studied and characterized than cigarettes. Small sheet-wrapped cigars, often called little cigars, are a subcategory of cigars that are similar to conventional ...
  9. CORESTA Congress, Kunming, 2018, Agronomy/Phytopathology Groups, APPOST 11

    Field trials with low nicotine tobacco varieties developed by conventional breeding technique: first results

    MALPICA A.(1); EVANS W.(2); ARCHIBALD C.(3); SCOTT L.(4); GARWE D.(5); CHAMANGO A.M.Z.(6); DORLHAC de BORNE F.(7); COLARD S.(8)
    (1) Bergerac Seed and Breeding, Bergerac, France; (2) Imperial Tobacco South Africa Pvt. Ltd, Umhlanga, Durban, South Africa; (3) Alliance One International Services, Camberley, Surrey, U.K.; (4) Universal Leaf Tobacco Co., Richmond, VA, U.S.A.; (5) Tobacco Research Board (TRB), Harare, Zimbabwe; (6) Agricultural Research & Extension Trust (ARET), Lilongwe, Malawi; (7) Imperial Tobacco Limited, Bergerac, France; (8) SEITA - Imperial Brands plc, Paris, France
    In 2015, the World Health Organisation (WHO) Study Group on Tobacco Product Regulation (“TobReg”) issued an advisory note recommending a strategy of reducing nicotine in tobacco to substantially lower levels of 0.4 mg/g. In the U.S., the Food and Drug ...